Page 36 - ebook HCC
P. 36



34 PROGRAMME AND ABSTRACTS GENEVA, SWITZERLAND EASL HCC SUMMIT 35
FEBRUARY 13 - 16, 2014










# Title Last name First Name # Title Last name First Name

MOLECULAR ANALYSIS OF THE GENE GSTP1 PREDICTORS OF HCC RECURRENCE
ALA114VAL POLYMORPHISM IN PATIENTS C53 FOLLOWING LIVER TRANSPLANTATION: THE Fatourou Evangelia
C45 Da Silva Renato F.
WITH CIRRHOSIS AND HEPATOCELLULAR SIGNIFICANCE OF ALPHA-FETOPROTEIN
CARCINOMA (HCC)
PROGENITOR CELL MARKERS IN
VASCULAR ENDOTHELIAL GROWTH FACTOR Da Silva Renato F. C54 HEPATOCELLULAR CARCINOMA: CLINICO- Fatourou Evangelia
PATHOLOGICAL CORRELATIONS AND
GENETIC VARIANTS RELATED TO GENDER
POSTER BOARDS IN HEPATOCELLULAR CARCINOMA AND PROGNOSTIC VALUE POSTER BOARDS
C46
CIRRHOSIS: PRELIMINARY RESULTS
ROLE OF 1H MR SPECTROSCOPY
THE MANAGEMENT OF SMALL
C47 CURATIVE TREATMENT IN Hefaiedh Rania C55 IN EVALUATING RESPONSE OF Ziada Dina H.
HEPATOCELLULAR CARCINOMA TO
HEPATOCELLULAR CARCINOMA RADIOFREQUENCY ABLATION"
RADIOEMBOLIZATION WITH YTTRIUM-90 RISK OF HCC AND ITS PREDICTORS IN
MICROSPHERES IN TREATMENT OF C56 VIRAL HEPATITIS COINFECTED PATIENTS Yesmembetov Kakharman I.
C48 ADVANCED HEPATOCELLULAR CARCINOMA El Fouly Amr
WITH VASCULAR INVASION; FIRST EGYPTIAN DEVELOPMENT OF HEPATOCELLULAR
PILOT STUDY CARCINOMA IN A HBEAG-NEGATIVE
CHRONIC HEPATITIS B PATIENT WITHOUT
C57 Günal Emine
CHUBBY IS BEATIFUL: SUBCUTANEOUS FAT CIRRHOSIS UNDER THE LONG-TERM
AREA AS PREDICTOR OF BETTER SURVIVAL VIROLOGICAL SUPPRESSION WITH
C49 Iegri Claudia
IN PATIENTS WITH HCC TREATED WITH LAMIVUDINE PLUS ADEFOVIR THERAPY
SORAFENIB
HEPATOCELLULAR CARCINOMA IN A
MICRO RNA SIGNATURE IN EGYPTIAN LONG-TERM SUSTAINED VIROLOGICAL
C50 PATIENTS WITH CHRONIC HEPATITIS C Omar Heba RESPONDER FOLLOWING PEGYLATED
RELATED HEPATOCELLULAR CARCINOMA C58 INTERFERON PLUS RIBAVIRIN Günal Emine
COMBINATION THERAPY FOR CHRONIC
HEPATOCELLULAR CARCINOMA IN POST HEPATITIS C
C51 VIRAL HEPATITIS CIRRHOTIC PATIENTS: A Asad Muhammad
STUDY FROM PAKISTAN HIGH LEVELS OF CIRCULATING
ENDOTHELIAL CELLS AND RISK OF
TREATMENT OF HEPATOCELLULAR PROGRESSION IN PATIENTS WITH
C52 CARCINOMA: A MONOCENTRIC TUNISIAN Romdhane Hayfa C59 LOCALLY ADVANCED OR METASTATIC Giovanis Petros
STUDY HEPATOCELLULAR CARCINOMA RECEIVING
SORAFENIB
   31   32   33   34   35   36   37   38   39   40   41